HawsGoodwin Investment Management’s iShares US Medical Devices ETF IHI Stock Holding History

HawsGoodwin Investment Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$4.4M	Sell	66,845 -145	-0.2%	-$9.28K	1.28%	21
2021 Q3	$4.21M	Sell	66,990 -6,822	-9%	-$435K	1.28%	21
2021 Q2	$4.44M	Sell	73,812 -53,856	-42%	-$3.11M	1.37%	21
2021 Q1	$7.03M	Sell	127,668 -16,854	-12%	-$935K	2.25%	13
2020 Q4	$7.88M	Buy	144,522 +4,104	+3%	+$215K	2.47%	12
2020 Q3	$7.01M	Buy	140,418 +8,370	+6%	+$405K	2.49%	13
2020 Q2	$5.83M	Buy	+132,048	New	+$5.64M	2.29%	13

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

OLVIG

Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

HawsGoodwin Investment Management's IHI Position: Q4 2021 in Review

HawsGoodwin Investment Management reduced its iShares US Medical Devices ETF (IHI) stake by 0.22% in Q4 2021, selling an estimated $9.28K and leaving 66,845 shares worth $4.4M. The position accounts for 1.28% of the portfolio, ranked #21.

HawsGoodwin Investment Management first reported a position in IHI in Q2 2020 and has held it in 7 quarters since. The position peaked at $7.88M in Q4 2020. 662 funds tracked by Wall St. Rank hold IHI as of Q4 2021.

HawsGoodwin Investment Management held 66,845 shares of iShares US Medical Devices ETF worth $4.4M as of Q4 2021.
HawsGoodwin Investment Management sold 145 iShares US Medical Devices ETF shares in Q4 2021, an estimated $9.28K.
iShares US Medical Devices ETF made up 1.28% of HawsGoodwin Investment Management's portfolio in Q4 2021, its #21 holding.
HawsGoodwin Investment Management first reported a position in iShares US Medical Devices ETF in Q2 2020 and has held it in 7 quarters since.
HawsGoodwin Investment Management's iShares US Medical Devices ETF position peaked at $7.88M in Q4 2020.
662 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2021.

Based on HawsGoodwin Investment Management's 13F filing for Q4 2021, filed 9 Feb 2022.